B Chevallier
Impact in
- Oncology top 2%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Neutropenia and Cancer Infections
- Cancer Research top 5%
- Breast Cancer Treatment Studies
Papers in
- Co-authors
- Henri Roché (11 shared papers)P. Fumoleau (13 shared papers)Jean Pierre Olivier (3 shared papers)Pierre Kerbrat (13 shared papers)P. Chollet (7 shared papers)P Hurteloup (5 shared papers)P. Fargeot (9 shared papers)N. Azli (4 shared papers)
- Journals
- European Journal of Cancer (9 papers)Journal of Clinical Oncology (5 papers)British Journal of Cancer (5 papers)Annals of Oncology (2 papers)International Journal of Gynecological Cancer (1 paper)
- Partner nations
- FranceBelgiumNetherlands
In The Last Decade
B Chevallier
69 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 102
- Oncology 905
- Cancer Research 385
- Dermatology 95
- Pathology and Forensic Medicine 156
- Surgery 371
Countries citing papers authored by B Chevallier
This map shows the geographic impact of B Chevallier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Chevallier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Chevallier more than expected).
Fields of papers citing papers by B Chevallier
This network shows the impact of papers produced by B Chevallier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Chevallier. The network helps show where B Chevallier may publish in the future.
Co-authors
The 25 scholars most cited alongside B Chevallier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 364 | |
| 2 | Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate. | 1993 | 218 |
| 3 | 1995 | 191 | |
| 4 | 1990 | 102 | |
| 5 | 1995 | 90 | |
| 6 | 1996 | 88 | |
| 7 | 1996 | 76 | |
| 8 | 1993 | 73 | |
| 9 | 1995 | 60 | |
| 10 | 1993 | 49 | |
| 11 | 2003 | 48 | |
| 12 | 1994 | 36 | |
| 13 | 1993 | 35 | |
| 14 | 1990 | 31 | |
| 15 | Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. The Granisetron Study Group. | 1990 | 27 |
| 16 | 1987 | 27 | |
| 17 | 1997 | 25 | |
| 18 | 1994 | 24 | |
| 19 | 1993 | 23 | |
| 20 | High-dose epirubicin in platinum-pretreated patients with ovarian carcinoma: the EORTC-GCCG experience. | 1995 | 21 |
About B Chevallier
B Chevallier is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Cancer Research and Pathology and Forensic Medicine, having authored 70 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (20 papers), Breast Cancer Treatment Studies (12 papers), Nausea and vomiting management (6 papers), Cancer Diagnosis and Treatment (5 papers), Breast Lesions and Carcinomas (5 papers), Sarcoma Diagnosis and Treatment (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). The work is most often cited by research in Oncology (905 citations), Cancer Research (385 citations), Dermatology (95 citations), Pathology and Forensic Medicine (156 citations) and Surgery (371 citations). B Chevallier has collaborated with scholars based in France, Belgium and Netherlands. Frequent co-authors include Henri Roché, P. Fumoleau, Jean Pierre Olivier, Pierre Kerbrat, P. Chollet, P Hurteloup, P. Fargeot, N. Azli, Véronique Dièras and A. Riva. Their work appears in journals such as European Journal of Cancer, Journal of Clinical Oncology, British Journal of Cancer, Annals of Oncology and International Journal of Gynecological Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.